Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Praveen Prasad

Neurological Surgery Sacramento, CA Medical Doctor

NPI 1811916638 CMS profile 218427

3000 Q St Fl 4, Ste 250, Sacramento, CA 95816

Open in the dashboard

General payments

$14,544

167 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Praveen Prasad of Sacramento, CA is reported in the CMS Open Payments database as having received $14,544 across 167 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27 1
2024 General $212 7
2023 General $1,383 22
2022 General $1,417 28
2021 General $4,185 27
2020 General $2,160 25
2019 General $5,161 57

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Praveen Prasad
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Praveen Prasad were reported at $27. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Praveen Prasad Neurological Surgery median Middle half National median
2019 $5,161 $582 $138–$3,006 $163
2020 $2,160 $294 $76–$2,174 $114
2021 $4,185 $387 $105–$2,432 $132
2022 $1,417 $542 $139–$2,989 $149
2023 $1,383 $534 $145–$2,697 $160
2024 $212 $574 $155–$3,046 $164
2025 $27 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nevro Corp. $5,214 73 payments
  2. Alphatec Spine, Inc $4,903 27 payments
  3. Spineart USA Inc $781 6 payments
  4. Cerapedics, Inc. $766 3 payments
  5. Globus Medical, Inc. $752 24 payments
  6. Foundation Fusion Solutions, LLC $474 2 payments
  7. Abbott Laboratories $268 9 payments
  8. Bioventus LLC $251 2 payments
  9. Axis360 Surgical Inc $230 2 payments
  10. Boston Scientific Corporation $195 5 payments
  11. Other $710 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,510 145 payments
  2. Travel and Lodging $4,007 18 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,000 1 payment
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,500 1 payment
  5. Honoraria $500 1 payment
  6. Consulting Fee $27 1 payment
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $3,383 17 payments
  2. Senza Spinal Cord Stimulation System $2,652 37 payments
  3. Omnia $2,359 20 payments
  4. LIF $938 6 payments
  5. i-FACTOR Putty $500 1 payment
  6. SCARLET AL-T $338 2 payments
  7. PERLA TL $283 2 payments
  8. I-FACTOR PEPTIDE ENHANCED BONE GRAFT $266 2 payments
  9. CREO MIS $225 1 payment
  10. Senza $202 16 payments
  11. Other $2,711 62 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$58,402

Medicare's payments for the services billed

Medicare patients

98

Average age 73

Services billed

229

49 women, 49 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 39%
Ischemic heart disease 33%
Depression 30%
Chronic kidney disease 24%
COPD 20%
Cancer 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

167 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record